Search

Search Results

• Book

  Pharmaceutical regulatory environment : challenges and opportunities in the Gulf Region

  Reem K. Al-Essa, Mohammed Al-Rubaie, Stuart Walker, Sam Salek.

  Contents:
  1. Overview of Medicines Regulatory Systems in the Gulf Region
  2. The Regulatory Review Process in the Gulf Region
  3. Regulatory Review Times in the Gulf Region
  4. Quality Measures in the Gulf Regulatory Practices
  5. The Current Status of the Common Technical Document
  6. The Current Status of Drug Safety and Pharmacovigilance
  7. The Centralized Regulatory Review in the Gulf Region
  8. The Gulf States Assessment and Experience With the Centralised Procedure
  9. The Pharmaceutical Companies Assessment and Experience With the Centralised Procedure
  10. Proposal For an Improved Centralized Regulatory System
  11. The Strategic Planning Process of the GCC Regulatory Authorities: Barriers And Solutions
  12. The Regulatory Dilemma in the Gulf Region: The Way Forward.

  Digital Access Springer 2015
  Get Shareable Link

  View Details
• Article

  Immundefekt-Syndrome--Hinweis auf einen WHO-Report. [Immunodeficiency syndromes--a new WHO report (author's transl)].

  Hitzig WH.

  Immun Infekt. 1979 Jun;7(3):93-6.

  This short note is meant to point out the importance of a new WHO publication on immunodeficiency syndromes (IDS), which was prepared by an expert committee. For the classification of primary IDS, three different principles are useful, each for particular purposes. For the first time, the importance and frequency of secondary IDS are discussed as well. The original report should be read by clinical immunologists, pediatricians, internists and others interested in IDS.

  Digital Access Access Options
  Get Shareable Link

  PubMed